Loading...
Loading...
In a report published Thursday, Stifel analyst Steven Rubis downgraded the rating on
WebMD Health Corp.WBMD from Buy to Hold, and removed the $52.00 price target.
In the report, Stifel noted, “We are downgrading shares of WebMD from Buy to Hold, as the preponderance of evidence associated with our channel checks reflect negative data trends and deterioration of possible positive catalysts seems to limit share price upside.”
WebMD Health Corp. closed on Wednesday at $40.25.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in